Rejuvenation by cell reprogramming: a new horizon in gerontology
- PMID: 30558644
- PMCID: PMC6296020
- DOI: 10.1186/s13287-018-1075-y
Rejuvenation by cell reprogramming: a new horizon in gerontology
Abstract
The discovery of animal cloning and subsequent development of cell reprogramming technology were quantum leaps as they led to the achievement of rejuvenation by cell reprogramming and the emerging view that aging is a reversible epigenetic process. Here, we will first summarize the experimental achievements over the last 7 years in cell and animal rejuvenation. Then, a comparison will be made between the principles of the cumulative DNA damage theory of aging and the basic facts underlying the epigenetic model of aging, including Horvath's epigenetic clock. The third part will apply both models to two natural processes, namely, the setting of the aging clock in the mammalian zygote and the changes in the aging clock along successive generations in mammals. The first study demonstrating that skin fibroblasts from healthy centenarians can be rejuvenated by cell reprogramming was published in 2011 and will be discussed in some detail. Other cell rejuvenation studies in old humans and rodents published afterwards will be very briefly mentioned. The only in vivo study reporting that a number of organs of old progeric mice can be rejuvenated by cyclic partial reprogramming will also be described in some detail. The cumulative DNA damage theory of aging postulates that as an animal ages, toxic reactive oxygen species generated as byproducts of the mitochondria during respiration induce a random and progressive damage in genes thus leading cells to a progressive functional decline. The epigenetic model of aging postulates that there are epigenetic marks of aging that increase with age, leading to a progressive derepression of DNA which in turn causes deregulated expression of genes that disrupt cell function. The cumulative DNA damage model of aging fails to explain the resetting of the aging clock at the time of conception as well as the continued vitality of species as millenia go by. In contrast, the epigenetic model of aging straightforwardly explains both biologic phenomena. A plausible initial application of rejuvenation in vivo would be preventing adult individuals from aging thus eliminating a major risk factor for end of life pathologies. Further, it may allow the gradual achievement of whole body rejuvenation.
Keywords: Aging; Cell reprogramming; Epigenetics; Rejuvenation; Therapeutic potential.
Conflict of interest statement
Ethics approval and consent to participate
All authors agree to publish this article and have accepted to abide the ethical standards of our institution.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures




Similar articles
-
Aging and rejuvenation - a modular epigenome model.Aging (Albany NY). 2021 Feb 24;13(4):4734-4746. doi: 10.18632/aging.202712. Epub 2021 Feb 24. Aging (Albany NY). 2021. PMID: 33627519 Free PMC article.
-
The Emerging View of Aging as a Reversible Epigenetic Process.Gerontology. 2017;63(5):426-431. doi: 10.1159/000477209. Epub 2017 May 25. Gerontology. 2017. PMID: 28538216
-
Multi-omic rejuvenation of human cells by maturation phase transient reprogramming.Elife. 2022 Apr 8;11:e71624. doi: 10.7554/eLife.71624. Elife. 2022. PMID: 35390271 Free PMC article.
-
Cellular reprogramming and epigenetic rejuvenation.Clin Epigenetics. 2021 Sep 6;13(1):170. doi: 10.1186/s13148-021-01158-7. Clin Epigenetics. 2021. PMID: 34488874 Free PMC article. Review.
-
A ride through the epigenetic landscape: aging reversal by reprogramming.Geroscience. 2021 Apr;43(2):463-485. doi: 10.1007/s11357-021-00358-6. Epub 2021 Apr 6. Geroscience. 2021. PMID: 33825176 Free PMC article. Review.
Cited by
-
Age reprogramming: Innovations and ethical considerations for prolonged longevity (Review).Biomed Rep. 2025 Apr 10;22(6):96. doi: 10.3892/br.2025.1974. eCollection 2025 Jun. Biomed Rep. 2025. PMID: 40297803 Free PMC article. Review.
-
Oct4, Sox2, Klf4, c-My (OSKM) gene therapy in the hypothalamus prolongs fertility and ovulation in female rats.Aging (Albany NY). 2025 Jan 24;17(1):161-169. doi: 10.18632/aging.206191. Epub 2025 Jan 24. Aging (Albany NY). 2025. PMID: 39864409 Free PMC article.
-
Aging and rejuvenation - a modular epigenome model.Aging (Albany NY). 2021 Feb 24;13(4):4734-4746. doi: 10.18632/aging.202712. Epub 2021 Feb 24. Aging (Albany NY). 2021. PMID: 33627519 Free PMC article.
-
Stem cells: past, present, and future.Stem Cell Res Ther. 2019 Feb 26;10(1):68. doi: 10.1186/s13287-019-1165-5. Stem Cell Res Ther. 2019. PMID: 30808416 Free PMC article. Review.
-
Cognitive rejuvenation in old rats by hippocampal OSKM gene therapy.Geroscience. 2025 Feb;47(1):809-823. doi: 10.1007/s11357-024-01269-y. Epub 2024 Jul 22. Geroscience. 2025. PMID: 39037528 Free PMC article.
References
-
- Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol. 1962;10:622–640. - PubMed
-
- Lapasset L, Milhavet O, Prieur A, Besnard E, Babled A, Aït-Hamou N, Leschik J, Pellestor F, Ramirez JM, De Vos J, Lehmann S, Lemaitre JM. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 2011;25:2248–2253. doi: 10.1101/gad.173922.111. - DOI - PMC - PubMed
-
- Mertens J, Paquola AC, Ku M, Hatch E, Böhnke L, Ladjevardi S, McGrath S, Campbell B, Lee H, Herdy JR, Gonçalves JT, Toda T, Kim Y, Winkler J, Yao J, Hetzer MW, Gage FH. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell. 2015;17:705–718. doi: 10.1016/j.stem.2015.09.001. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources